| Serial Number | 79339835 |
| Word Mark | ASCENTAGE PHARMA |
| Filing Date | Monday, March 14, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 7, 2023 |
| Registration Number | 7209445 |
| Registration Date | Tuesday, November 7, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 22, 2023 |
| Description of Mark | The mark consists of a stylized letter A incorporating a curved band to the left of the stylized wording ASCENTAGE PHARMA. |
| Disclaimer with Predetermined Text | "PHARMA" |
| Goods and Services | Scientific and medical research services, namely, studies for combined compound functional mechanism on animals; cancer research for medical purposes; pharmaceutical research and development, namely, early evaluation for implementation of the new drugs; pharmaceutical research; scientific surveys for medical purposes; chemical analysis services; research and analysis in the field of biochemistry; chemical research service; scientific and medical research services in the nature of chemical analysis assessment service; chemical research and analysis; scientific and medical research services in the nature of chemical synthesis assessment service; chemical analysis; chemistry consulting services; chemical research; cosmetic research; structural and functional analysis of genomes; stem cell research services; biotechnological research; blood analysis service; genetic screening for scientific purposes; biological cloning services; research and development of antibodies; genetic testing for scientific research purposes; bacteriological research and analysis; biomedical research; medical research; pharmaceutical drug development; medical laboratory service; development of pharmaceutical preparations and pharmaceuticals; medical research service; biological research and analysis; bacteriological research; biological research; scientific and medical research, namely conducting clinical trials for others; computer programming of medical aspects; scientific and technical services, namely, testing and evaluation of pharmaceuticals; pharmaceutical research |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 6, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Jiangsu Ascentage Pharma Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Jiangsu Ascentage Pharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Jiangsu Ascentage Pharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Monday, March 4, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, February 26, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, February 26, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, February 26, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, February 8, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, February 8, 2024 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 7, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 7, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 7, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 31, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, October 11, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 11, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, August 22, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 22, 2023 | PUBLISHED FOR OPPOSITION |
| Monday, August 21, 2023 | NOTIFICATION PROCESSED BY IB |
| Wednesday, August 2, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 2, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 2, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, July 17, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 12, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 15, 2023 | REFUSAL PROCESSED BY IB |
| Wednesday, February 22, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, February 22, 2023 | REFUSAL PROCESSED BY MPU |
| Tuesday, December 27, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, December 26, 2022 | NON-FINAL ACTION WRITTEN |
| Sunday, December 25, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, May 10, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 6, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 5, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |